Junwei Hao

18PUBLICATIONS
43CO-AUTHORS
Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyCentral nervous systemNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 16, 2026
Clinical safety and preliminary efficacy of allogeneic human induced pluripotent stem cell-derived exosomes in patients with acute ischaemic stroke: protocol of a phase I/II clinical trial in China.

|Jul 20, 2026
Exploring Between-Study Heterogeneity in Extended-Window IV Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis of 18 Randomized Controlled Trials.

|Jun 24, 2026
Clinical and Modifiable Factors Associated With Disability and Relapse in MOGAD: A Multicentre Cohort Study.

|Jan 08, 2026
Chinese neuroimmunological disease (NIDBase) cohort study: cohort profile.

Mengyao Zhang, Jinming Han, Jiangwei Xia

|Oct 31, 2025
A multicenter, prospective, randomized, open-label, blinded endpoint trial of intravenous thrombolysis with tenecteplase for acute non-large vessel occlusion in extended time window (OPTION): Rationale and design.

Gaoting Ma, Ran Mo, Yingting Zuo

|Oct 02, 2025
Platelet activation plays a pro-inflammatory role in myasthenia gravis.

Qi Wen, Shu Zhang, Yaye Wang

Pageof 3

Frequent Collaborators

4 joint publications

Qingfeng Ma

3 joint publications

Gaoting Ma

2 joint publications

Thanh N Nguyen

2 joint publications

Yi Ren